| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6K | -45.5% |
| Cost of Revenue | $2K | -50.1% |
| Gross Profit | $4K | -42.3% |
| R&D Expense | $2.3M | -5.9% |
| SG&A Expense | $3.8M | +16.2% |
| Operating Income | -$6.1M | -6.9% |
| Pre-tax Income | -$6.0M | -9.1% |
| Income Tax | $0 | — |
| Net Income | -$6.0M | -9.1% |
| EPS (Diluted) | -$2.52 | +32.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Inventory | $0 | -100.0% |
| Current Assets | $7.4M | +20.6% |
| Total Assets | $7.8M | +17.1% |
| Current Liabilities | $285K | -13.1% |
| Total Liabilities | $285K | -13.1% |
| Stockholders' Equity | $7.5M | +18.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.9M | -10.5% |
| Investing Cash Flow | -$51K | -100.8% |
| Financing Cash Flow | $7.2M | +393.2% |